© 1996 American Heart Association, Inc.
Articles |
Thrombotic Risk in Hereditary Antithrombin III, Protein C, or Protein S Deficiency
A Cooperative, Retrospective Study
From the First Department of Medicine, Division of Hematology and Blood Coagulation (I.P.), and the Institute for Medical Statistics (B.S.), University of Vienna (Austria).
Abstract A cooperative, retrospective study was performed on data from 8 coagulation laboratories and thrombosis units in Austria, Germany, and Switzerland to assess the risk for thrombosis in patients with hereditary antithrombin III (AT-III), protein C (PC), and protein S (PS) deficiencies; to compare the clinical manifestations of these 3 deficiency states; and to estimate the risk for development of thrombosis in high-risk situations. Two hundred thirty patients from 71 families with a documented hereditary deficiency of a natural coagulation inhibitor were included in the study. The patient group comprised 69 patients from 25 families with AT-III deficiency, 86 patients from 27 families with PC deficiency, and 75 patients from 19 families with PS deficiency. Diagnosis of the deficiency state was made at each participating center. Clinical data were documented in a questionnaire that was completed during each patient's visit to the participating center. The questionnaires were sent to the coordinating center (Vienna) and analyzed centrally. The probability of developing thrombosis was 80% to 90% for all deficiency states by 50 to 60 years of age, and this figure did not change considerably after data from the propositi were excluded. AT-III–deficient females developed thrombosis earlier in life compared with PC- and PS-deficient females due to a high thrombotic risk during pregnancy (40% in patients with AT-III deficiency) and oral contraceptive use. The clinical features of thromboembolism were similar in the three deficiency states except for a higher frequency of superficial thrombophlebitis in patients with PC and PS deficiencies. Mesenteric vein thromboses occurred in 4% to 10% of patients and in 2 of 8 patients as a recurrent event. The recurrence rate was 63% (60% of recurrent events occurred spontaneously) and did not differ significantly among the three deficiency states. Before 14 years of age only 1 of 80 surgical procedures and 0 of 21 leg injuries were followed by thrombosis. After 14 years of age thromboembolic events occurred after abdominal surgery or leg injury in one third of patients. Between 40% and 50% of symptomatic patients reported that they felt handicapped by a postthrombotic syndrome. We conclude that diagnosis of a coagulation inhibitor deficiency state should be made before 14 years of age. During childhood thrombosis prophylaxis cannot be regularly recommended but should be instituted after 13 years of age during/after abdominal surgery, including appendectomy, and after leg injury in AT-III–, PC-, and PS-deficient patients. The high recurrence rate (60% spontaneous recurrence) and the relatively high frequency of mesenteric vein thrombosis as a recurrent event favor introduction of long-term oral anticoagulant treatment after the first thrombotic event in patients with a documented hereditary deficiency of AT-III, PC, or PS.
Key Words: antithrombin III deficiency • protein C deficiency • protein S deficiency • natural inhibitor deficiency • thrombotic risk
This article has been cited by other articles:
 |
|
 |
|
  T. Zhu, I. Martinez, and J. Emmerich Venous Thromboembolism: Risk Factors for Recurrence Arterioscler. Thromb. Vasc. Biol., March 1, 2009; 29(3): 298 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Salmon and P. de Groot Pathogenic role of antiphospholipid antibodies Lupus, May 1, 2008; 17(5): 405 - 411. [Abstract] [PDF]
|
|
|
|
 |
|
 N. A. Goldenberg Thrombophilia States and Markers of Coagulation Activation in the Prediction of Pediatric Venous Thromboembolic Outcomes: A Comparative Analysis with Respect to Adult Evidence Hematology, January 1, 2008; 2008(1): 236 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Merriman and M Greaves Testing for thrombophilia: an evidence-based approach Postgrad. Med. J., November 1, 2006; 82(973): 699 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schneppenheim and J. Greiner Thrombosis in Infants and Children Hematology, January 1, 2006; 2006(1): 86 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Y. Vossen, I. D. Walker, P. Svensson, J. C. Souto, I. Scharrer, F. E. Preston, G. Palareti, I. Pabinger, F. J.M. van der Meer, M. Makris, et al. Recurrence Rate After a First Venous Thrombosis in Patients With Familial Thrombophilia Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1992 - 1997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Leon Jr and N. Labropoulos Superficial Vein Thrombosis and Hypercoagulable States: The Evidence Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2005; 17(1): 43 - 46. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Brenner Clinical management of thrombophilia-related placental vascular complications Blood, June 1, 2004; 103(11): 4003 - 4009. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. McBane II Genetically Determined Procoagulant States and Heparin Use Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2003; 7(4): 427 - 442. [Abstract] [PDF]
|
|
|
|
 |
|
 C. J. J. van Dongen, R. Vink, B. A. Hutten, H. R. Buller, and M. H. Prins The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event: A Meta-analysis Arch Intern Med, June 9, 2003; 163(11): 1285 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-C. Hauser, I. Pabinger-Fasching, P. Quehenberger, J. Kettenbach, and W. H. Horl A patient with sudden abdominal pain 10 years after successful renal transplantation Nephrol. Dial. Transplant., May 1, 2003; 18(5): 1021 - 1025. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Simsic, W. E. Uber, J. Lazarchick, and S. M. Bradley Systemic-to-pulmonary artery shunt thrombosis in a neonate with factor V Leiden mutation Ann. Thorac. Surg., December 1, 2002; 74(6): 2179 - 2181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Hausler, D Hubner, T Delhaas, and E G Muhler Long term complications of inferior vena cava thrombosis Arch. Dis. Child., September 1, 2001; 85(3): 228 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Pabinger, H. Grafenhofer, A. Kaider, A. Ilic, S. Eichinger, P. Quehenberger, P. Husslein, C. Mannhalter, and K. Lechner Preeclampsia and Fetal Loss in Women With a History of Venous Thromboembolism Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 874 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Seligsohn and A. Lubetsky Genetic Susceptibility to Venous Thrombosis N. Engl. J. Med., April 19, 2001; 344(16): 1222 - 1231. [Full Text] [PDF]
|
|
|
|
 |
|
 I. D Walker Thrombophilia in pregnancy J. Clin. Pathol., August 1, 2000; 53(8): 573 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Baglin Thrombophilia testing: what do we think the tests mean and what should we do with the results? J. Clin. Pathol., March 1, 2000; 53(3): 167 - 170. [Full Text] [PDF]
|
|
|
|
 |
|
 M. de Swiet Review Article: Management of pulmonary embolus in pregnancy Eur. Heart J., October 1, 1999; 20(19): 1378 - 1385. [PDF]
|
|
|
|
|
|
R. D. Rosenberg and W. C. Aird Vascular-Bed-Specific Hemostasis and Hypercoagulable States N. Engl. J. Med., May 20, 1999; 340(20): 1555 - 1564. [Full Text] [PDF]
|
|
|
|
|
|
P. Bucciarelli, F. R. Rosendaal, A. Tripodi, P. M. Mannucci, V. De Stefano, G. Palareti, G. Finazzi, F. Baudo, and R. Quintavalla Risk of Venous Thromboembolism and Clinical Manifestations in Carriers of Antithrombin, Protein C, Protein S Deficiency, or Activated Protein C Resistance : A Multicenter Collaborative Family Study Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 1026 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Martinelli, P. M. Mannucci, V. De Stefano, E. Taioli, V. Rossi, F. Crosti, K. Paciaroni, G. Leone, and E. M. Faioni Different Risks of Thrombosis in Four Coagulation Defects Associated With Inherited Thrombophilia: A Study of 150 Families Blood, October 1, 1998; 92(7): 2353 - 2358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Laffan Genetics and pulmonary medicine bullet 4: Pulmonary embolism Thorax, August 1, 1998; 53(8): 698 - 702. [Full Text]
|
|